Editorial

Brian F. Mandell, MD, PhD
Department of Rheumatic Diseases, The Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, Deputy Editor, Cleveland Clinic Journal of Medicine, NA32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Brian F. Mandell, MD, PhD
Department of Rheumatic Diseases, The Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, Deputy Editor, Cleveland Clinic Journal of Medicine, NA32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Brian F. Mandell, MD, PhD
Department of Rheumatic Diseases, The Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, Deputy Editor, Cleveland Clinic Journal of Medicine, NA32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Christopher M. Bono, MD
Department of Orthopaedic Surgery, Boston Medical Center

Address: Christopher M. Bono, MD, Department of Orthopaedic Surgery, Boston Medical Center, 850 Harrison Avenue, Dowline 2 North, Boston, MA 02118; email: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Christopher M. Bono, MD
Department of Orthopaedic Surgery, Boston Medical Center

Address: Christopher M. Bono, MD, Department of Orthopaedic Surgery, Boston Medical Center, 850 Harrison Avenue, Dowline 2 North, Boston, MA 02118; email: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Christopher M. Bono, MD
Department of Orthopaedic Surgery, Boston Medical Center

Address: Christopher M. Bono, MD, Department of Orthopaedic Surgery, Boston Medical Center, 850 Harrison Avenue, Dowline 2 North, Boston, MA 02118; email: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Steven M. Gordon, MD
Hospital Epidemiologist, Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S31, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Steven M. Gordon, MD
Hospital Epidemiologist, Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S31, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Steven M. Gordon, MD
Hospital Epidemiologist, Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S31, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

George L. Blackburn, MD, PhD
S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215; e-mail [email protected]

Dr. Blackburn has indicated that he has received grant or research support from the Robert C. Atkins Foundation, Inc.

George L. Blackburn, MD, PhD
S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215; e-mail [email protected]

Dr. Blackburn has indicated that he has received grant or research support from the Robert C. Atkins Foundation, Inc.

George L. Blackburn, MD, PhD
S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215; e-mail [email protected]

Dr. Blackburn has indicated that he has received grant or research support from the Robert C. Atkins Foundation, Inc.